Focused on the research and development and production of resin materials and resin end products - Hebei Lijiang
-
AboutHebei Lijiang Biotechnology Co., Ltd. is a new material manufacturer specializing in the production of functional special ion exchange resins and disposable blood perfusion devices. It is a modern high-tech enterprise integrating the research and development, production, sales, and service of resin materials and resin end products. The company was established in April 2014 with a registered capital of 52 million yuan. It plans to cover an area of 267 acres and is located in the High-tech Industrial Park of Weixian County, Hebei Province—New Material Demonstration Park. The total investment is 510 million yuan. It is a council member unit of the Ion Exchange Resin Branch of the China Membrane Industry Association.
-
Product
-
BlogsThe company will focus on the high-end market, with the purpose of serving society, solidly carrying out technological innovation and product promotion, continuously improving the development and expansion of ion exchange resin products in emerging application fields, thereby promoting the upgrading and development of related industries.
-
Company AlbumThe current phase of construction has been fully completed and put into operation, featuring a comprehensive workshop with 42 production lines for functional ion exchange resins with an annual output of 16,800 tons and a production capacity of 30,000 tons, a wastewater treatment plant with an annual treatment capacity of 403,000 tons, and a workshop producing 5,000 tons of medical-grade magnesium sulfate annually. Trial production began in July 2016, with official production starting in January 2017.
Hebei Lijiang Biotechnology Co., Ltd. Annual Production of 2100 Tons of Medical Resin Project Environmental Impact Assessment First Information Disclosure
Release Time:
2025-03-28
To fully understand the opinions of all sectors of society on the construction of Hebei Lijiang Biotechnology Co., Ltd.'s project for an annual production of 2,100 tons of medical resin, and to better carry out environmental protection work, the relevant matters of the construction project are hereby announced in accordance with the "Measures for Public Participation in Environmental Impact Assessment" (Order No. 4 of the Ministry of Ecology and Environment) and other related requirements.
河北利江生物科技有限公司年产2100吨医用树脂项目
环境影响评价第一次信息公示
为充分了解社会各界对河北利江生物科技有限公司年产2100吨医用树脂项目建设的意见，更好地做好环境保护工作，根据《环境影响评价公众参与办法》(生态环境部部令第4号)等的相关要求，将建设项目有关事项公示如下：
一、建设项目概况
项目名称：河北利江生物科技有限公司年产2100吨医用树脂项目
建设地点：河北威县高新技术产业开发区建设东路2号
主要建设内容及规模：项目占在公司院内预留空地上扩建4F框架结构生产车间1座，新增建筑面积3800平方米，购置安装反应釜、储罐、冷凝器、筛分机等设备。外购甲苯、甲醇等原辅料进行加工生产，聚苯乙烯中性大孔树脂主要工序有常压聚合、甲基化、后交联，螯合树脂主要工序主要有酰胺化、萃取蒸馏、水解，丙烯酸树脂主要工序有伯胺基化、萃取蒸馏、甲基化。项目投产达效后年生产聚苯乙烯中性大孔树脂100吨、螯合树脂1000吨、丙烯酸树脂1000吨。
项目总投资：本项目总投资13000万元。
二、建设单位名称及联系方式
建设单位：河北利江生物科技有限公司
通讯地址：河北威县高新技术产业开发区建设东路2号
联系人：张工 联系电话：13383698965
三、环境影响报告书编制单位名称及联系方式
环评单位：河北绿智星澜环境科技有限公司
通讯地址：河北省石家庄市长安区中山东路447号建华城市广场A座2202-01号
联系人：王工 联系电话：15733176800
四、公众意见表的获取方式
链接: https://pan.baidu.com/s/1S9s0UGsKVbLHxX2CaAbzWQ?pwd=ljgc
提取码: ljgc。
五、公众提出意见的方式和途径
即日起，公众可通过信函、电子邮件或建设单位提供的其他方式，将填写的公众意见表等提交建设单位，反映与建设项目环境影响有关的意见和建议。
公众提交意见时，请提供有效的联系方式。以便及时反馈。
环境影响评价单位将在本项目《环境影响报告书》中真实记录公众的意见和建议，并将公众的宝贵意见、建议向项目的建设单位、设计单位和政府环保部门反映。
河北利江生物科技有限公司
2025年3月28日
Keyword:
Recommended Reading
24-05-14 14:37:56
